FEMACEUTICALS Trademark Information

Trademark by Femaceuticals, L.L.C.

Medical devices, namely, both pads and tampons for use in treating vaginal and vulvar tissue irritation, pads for treating breast and nipple irritation in nursing mothers, pads for use in treatment of infant diaper rash and adult incontinence rash, and pads for peri-anal use in treatment of hemorrhoidal irritation

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 6/19/2007
First Use In Commerce: 6/19/2007
General Information
Word mark: FEMACEUTICALS
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
6/22/2018
Serial Number: 76654243
Filing Date: 1/30/2006
Registration Number: 3340580
Registration Date: 11/20/2007
Goods and Services: Medical devices, namely, both pads and tampons for use in treating vaginal and vulvar tissue irritation, pads for treating breast and nipple irritation in nursing mothers, pads for use in treatment of infant diaper rash and adult incontinence rash, and pads for peri-anal use in treatment of hemorrhoidal irritation
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 10/31/2006
Last Applicant/Owner:
Femaceuticals, L.L.C.
Larchmont, NY 10538
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
O'Shea Getz P.C.
1500 Main Street, Suite 912
Springfield MA 01115
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
6/22/2018
Correspondent Search:
Richard D. Getz is a correspondent of FEMACEUTICALS trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on